Joinn Laboratories(China)Co.,Ltd. (SHA:603127)

Market Cap	25.02B +134.8%
Revenue (ttm)	1.67B -21.5%
Net Income	225.09M
EPS	0.32
Shares Out	733.37M
PE Ratio	115.06
Forward PE	47.09
Dividend	0.03 (0.07%)
Ex-Dividend Date	Aug 14, 2025

Volume	9,866,988
Average Volume	14,858,228
Open	35.80
Previous Close	35.92
Day's Range	35.79 - 37.08
52-Week Range	15.12 - 45.95
Beta	1.00
RSI	43.34
Earnings Date	Mar 31, 2026

About SHA:603127

Joinn Laboratories(China)Co.,Ltd. provides preclinical and non-clinical services in the United States, the People’s Republic of China, and internationally. It operates through three segments: Non-Clinical Studies Services; Clinical Trial and Related Services; and Sales of Research Models. The Non-Clinical Studies Services segment offers drug safety assessment, drug metabolism and pharmacokinetics DMPK studies, and pharmacology and efficacy studies. Its Clinical Trial and Related Services segment provides clinical contract research organization ...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1995
• Employees: 2,551
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603127

Financial Performance

In 2024, SHA:603127's revenue was 2.02 billion, a decrease of -15.07% compared to the previous year's 2.38 billion. Earnings were 74.08 million, a decrease of -81.34%.